The BUILD-3 Trial: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study Of Bosentan In Idiopathic Pulmonary Fibrosis

american thoracic society international conference(2010)

引用 3|浏览12
暂无评分
关键词
idiopathic pulmonary fibrosis,bosentan,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要